Cory berkland
Abstract. Lung surfactant is crucial for optimal pulmonary function throughout life. An absence or deficiency of surfactant can affect the surfactant pool leading to respiratory distress. Even if the coupling between surfactant dysfunction and the underlying disease is not always well understood, using exogenous surfactants as replacement is ... Our clinical studies will determine if BBI-001 can reduce or eliminate the need for lifelong phlebotomies in Hereditary Hemochromatosis patients,” said Dr. Cory Berkland, Bond’s CEO, Chairman ...Cory Berkland. 2004, Biomaterials. Improved control of surface micro-and nano-structure may lead to enhanced performance of degradable biomedical devices such as surgical dressings, vascular grafts, tissue engineering scaffolds, sutures, and structures for guided tissue regeneration. An electrohydrodynamic method called flow-limited field ...
Did you know?
Abstract: Particles for delivery of active ingredients formed from an active ingredient and a hydrophobic matrix, as well as methods for making such particles. Type: Grant. Filed: August 16, 2019. Date of Patent: February 14, 2023. Assignee: ADARE PHARMACEUTICALS USA, INC. Inventors: Cory Berkland, Milind Singh.A method of forming particles comprises accelerating a stream comprising a liquid; and vibrating the stream, to form particles. The particle may have a diameter that is smaller than the diameter of the nozzle used to form the stream, allowing for the formation of micro- and nano-sized particle.I am pleased to announce here that the following individuals have accepted reappointments to the JPharmSci® EAB for another 3-year term (January 1, 2012-December 31, 2014): Cory Berkland, University of Kansas; David N. Brems, Newbury Park, California; Mino R. Caira, University of Cape Town; John H.Chad J Pickens 1 , Stephanie N Johnson 1 , Melissa M Pressnall 1 , Martin A Leon 2 , Cory J Berkland 1 2 3 Affiliations 1 Department of Pharmaceutical Chemistry , University of Kansas , 2095 Constant Avenue , Lawrence , Kansas 66047 , United States.Min Huang 1 , Samadhi N Vitharana, Laura J Peek, Tina Coop, Cory Berkland. Affiliation 1 Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, USA. PMID: 17428030 DOI: 10.1021/bm061211k Abstract Angiogenesis has long been a desired therapeutic approach to improve clinical outcomes of conditions typified by ...Jun Yang, 1, 2 Sheng-Xue Xie, 3 Yiling Huang, 1, 4 Min Ling, 1 Jihong Liu, 2 Yali Ran, 1 Yanlin Wang, 4 J Brantley Thrasher, 1 Cory Berkland, 3 and Benyi Li *, 1, 4 ... C Berkland would like to acknowledge supports for the project from the Coulter Foundation, the NIH (AR054035) and the NSF (0966614).Berkland serves as the Chairman of the Board, President, Chief Executive Officer (CEO), and Co-Founder of Bond Biosciences. He is taking a part ial leave as Distinguished Professor at The University of Kansas to advance the business and to ensure the development and clinical trial progression of BBI-001.Cory BERKLAND | Cited by 10,054 | of University of Kansas, Kansas (KU) | Read 244 publications | Contact Cory BERKLANDAdding trainee for Cory Berkland Type a name and select match from the drop-down list. If no match exists, you will be prompted to add a new person to the tree. Name: School: Department: Relationship: Comments: Cancel Save. Adding mentor for Cory Berkland Type a name and select match from the drop-down list. ...pH-responsive microgels are crosslinked polymer colloid particles that swell when the pH approaches the pK a of the polybase or polyacid chains. Poly(vinylamine) (PVAM) has the highest primary amine content of all amine-containing polymers.Despite much effort the preparation of colloidally stable PVAM microgels is still elusive.A new pH-sensitive triblock copolymer, polyethylene glycol-block-poly(2-dimethylaminoethyl methacrylate)-block-poly(2-diisopropylaminoethyl methacrylate) (PEG-PDMA-PDPA), was synthesized via atom transfer radical polymerization (ATRP).The potential of this polymer for siRNA delivery was assessed. This triblock copolymer formed nanocapsules with high siRNA encapsulation efficiency that ...Search 4 grants from Maria Flynn Search 22 grants from Cory Berkland Search grants from Ronald Beyerinck Search grants from David Newbold Search grants from Orbis Biosciences, Inc.Pulmonary delivery of cisplatin-hyaluronan conjugates via endotracheal instillation for the treatment of lung cancer Yumei Xiea, Kristin L. Aillona, Shuang Caia, Jason M. Christianb, Neal M. Daviesc, Cory J. Berklanda,b, and M. Laird Forresta,* aDepartment of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, 66047 USA bDepartment of Chemical and Petroleum Engineering, University of ...Corporate Faith - 2023 Business Speakers Series - Cory Berkland. Mon, Aug 14, 6:00 PM. Undivided Experience Center • Chesterfield, MO. Free. Save Corporate Faith - 2023 Business Speakers Series - Cory Berkland to your collection.PARKVILLE, Mo.--(BUSINESS WIRE)-- Bond Biosciences, Inc."We are pleased to begin this first-in-human clinical trial of our lead non-absorbed oral therapy and thankful for the seasoned development team that contributed to this significant milestone," said Dr. Cory Berkland, Bond's CEO, Chairman of the Board and Co-founder.Cory Berkland Songyot Anuchapreeda: Authors: Singkome Tima Siriporn Okonogi Chadarat Ampasavate Chad Pickens Cory Berkland Songyot Anuchapreeda: Keywords: Pharmacology, Toxicology and Pharmaceutics: Issue Date: 1-Dec-2016: Abstract:Jun 30, 2023 · Cory Berkland joins the faculty Nov. 1 from The University of Kansas, where he is the Solon E. Summerfield Distinguished Professor of Chemical and Petroleum Engineering and Pharmaceutical Chemistry. He has been on the faculty since 2003. Chittasupho C, Xie S-X, Baoum A, Yakovleva T, Siahaan TJ, Berkland CJ. ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells. European Journal of Pharmaceutical Sciences. 2009; …
Chandrashekar Raman 1 , Cory Berkland, Kyekyoon Kim, Daniel W Pack. Affiliation 1 Department of Chemical and Biomolecular Engineering, University of Illinois, Urbana, IL 61801, United States. PMID: 15773062 DOI: 10.1016/j.jconrel.2004.11.012 Abstract Modeling release of small molecules from degradable microspheres is important to the design of ...The professors also say international students subsidize domestic students and if expelled from higher education in the states, colleges and universities - whose budgets have already been hit hard ...Ross Palmer, D.V.M./M.S./DACVS Clinical Sciences - Surgical Research Colorado State UniversityCory Berkland The University of Kansas Verified email at ku.edu. Stevin H. Gehrke University of Kansas Verified email at ku.edu. ... M Singh, L Wang, CJ Berkland, MS Detamore. Annals of biomedical engineering 38, 2167-2182, 2010. 136: 2010: Development and quantitative characterization of the precursor rheology of hyaluronic acid hydrogels for ...
Ruolin Lu, 1 Chad Groer, 2 Peter A. Kleindl, 1 K. Ryan Moulder, 1 Aric Huang, 1 Jordan R. Hunt, 1 Shuang Cai, 1, 2 Daniel J. Aires, 2, 3 Cory Berkland, 1 and Laird Forrest 1, 2, * Ruolin Lu 1 Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KansasCory Berkland, PhD, has demonstrated Precision Particle Fabrication’s capabilities for more than a decade. Cory has a PhD in Chemical and Biomolecular Engineering from the University of Illinois, Urbana-Champaign, where he co-invented and developed the Orbis technology. Cory is a Professor of Pharmaceutical Chemistry and Chemical and ...Nanoparticles, Nanocapsules And Nanogels. Acid-labile poly (N-vinyl formamide) ("PNVF") nanocapsules were synthesized by free radical polymerization of N-vinyl formamide with optional active ingredients on the surface of silica nanoparticles. Polymerization in the presence of a novel cross-linker that contains an acid-labile ketal ...…
Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Hartwell BL; Pickens CJ; Leon M; Berkland. Possible cause: Jun 6, 2016 · 1. INTRODUCTION. Hyaluronic acid (HA) is a linear biopolymer compo.
Orion BioScience was founded by Dr. Joshua Sestak and Prof. Cory Berkland and the company is based out of Omaha, Nebraska.----Cory Berkland The University of Kansas Lawrence, KS. Joel Bernstein New York University Abu Dhabi Abu Dhabi, United Arab Emirates. Michael Blaber Florida State University Tallahassee, FL. Robin H. Bogner University of Connecticut Storrs, CT. Kathleen MK Boje State University of Buffalo Amherst, NY.I would like to sincerely and gratefully thank my advisor, Dr. Cory Berkland, for all of his support, guidance, patience, understanding, and most importantly, his friendship during my graduate studies at The University of Kansas. I have been fortunately blessed to have an advisor who gave me a great opportunity to develop my own individuality by
Cory Berkland. 2006, Journal of Pharmaceutical Sciences. Rapid advancement of the understanding of the structure and function of cell adhesion molecules (i.e., integrins, cadherins) has impacted the design and development of drugs (i.e., peptide, proteins) with the potential to treat cancer and heart and autoimmune diseases. For example, RGD ...ICAM-1 mobility on the cell surface leads to a phenomenon called “clustering” during ligand binding 34. The size of ICAM-1 and the steric hindrance effect are two significant factors in receptor clustering during ligand binding to ICAM-1, dictating that the receptors stay at an optimum distance from each other 35 – 36.
Cory Berkland. [email protected]; Departmen Cory Berkland. [email protected]; Department of Chemical and Petroleum Engineering, The University of Kansas, 2030 Becker Drive, Lawrence, Kansas 66047. Department of Pharmaceutical Chemistry, The University of Kansas, 2030 Becker Drive, Lawrence, Kansas 66047.Burkholderia pseudomallei, the etiological agent responsible for melioidosis, exhibits a great public health toll in its endemic regions. The elevation of B. pseudomallei to a Tier I select agent underscores the urgent need for effective therapeutics and preventatives. The current treatment regimen for melioidosis is suboptimal, requiring an intensive phase of intravenous antibiotic followed ... Dr. Cory J. Berkland, Committee Chair February 3rThe company's lead candidate, BBI-001, is an iron ch Acute B-Cell Inhibition by Soluble Antigen Arrays is Valency-Dependent and Predicts Immunomodulation in Splenocytes J. Daniel Griffin1, Martin A. Leon2, Jean R. Salash3, Michael Shao4, Brittany L. Hartwell1, Chad J. Pickens3, Joshua O. Sestak3, Cory Berkland1,3,4 1Bioengineering Graduate Program, University of Kansas, Lawrence, KS 2Department of Chemistry, University of Kansas, Lawrence, KS C. Berkland, K. Kim, and D.W. Pack (2004) Controlling double- Cory Berkland Zahra Mohammadi Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) University of Kansas Original Assignee University of Kansas Priority date (The priority date is an assumption and is not a legal conclusion.Moderators: Dr. Cory Berkland and Dr. Omar Aljitawi 10-10:20 A.M. Dr. Cory Berkland Mimicking Properties of Natural Biomaterials as a Stem Cell Niche 10:20-10:40 A.M. Dr. Mei He 3D Printing Approaches to Creating Precise Cell Microenvironments 10:40-11 A.M. Dr. Wayne Godfrey YESCARTA (Axicabtagene Ciloleucel): Three decades of promise have culminated in the development of gene Cory Berkland PhD, VP Strategic Development. Kingdom Capital PortCory Berkland, Solon E. Summerfield Distinguished Professor; Stev Conflict of interest C. Berkland has a patent (US 20110287547 A1) on Ca-TAT peptides. These studies were not solicited or funded by any pharmaceutical company. ... Cory Berkland, Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS … Integrated Science Building (ISB) 1567 Irv "We are pleased to begin this first-in-human clinical trial of our lead non-absorbed oral therapy and thankful for the seasoned development team that contributed to this significant milestone," said Dr. Cory Berkland, Bond's CEO, Chairman of the Board and Co-founder. Aug 2, 2016 · Fang WB, Yao M, Jokar I, Alhakamy N, Berkland[Cory Berkland, Ph.D.-Solon E. Summerfield Distinguished ProfCory Berkland spun Austin, Texas-based Savara Inc. out of J Daniel Griffin Sebastian G Huayamares Towne R Walston Jimmy Y Song Michael Shao Alexander R Sedlacek Deanna L Diaz Aparna R Chakravarti Cory J Berkland ACS Appl Bio Mater 2021 01 23;4(1):387-391. Epub 2020 Dec 23.Cory BERKLAND | Cited by 10,054 | of University of Kansas, Kansas (KU) | Read 244 publications | Contact Cory BERKLAND